Impact of Tenofovir Alafenamide Sub‐Dermal Implant Insertion Site Scarring on Acceptability and HIV Prevention Preferences: A Prospective Cohort Study in Durban, South Africa

Documenti analoghi

• The audacious goal to end AIDS by 2030: aspiration or reality?
  di: Quarraisha Abdool Karim, et al.
  Pubblicazione: (2024)
• BIKSWITCH Study: Effectiveness and Safety of Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Therapies Not Based on Integrase Inhibitors in Virologically Suppressed HIV‐Infected Patients
  di: Fernando Pérez-Calvo, et al.
  Pubblicazione: (2025)
• Advancements and Challenges in Eliminating Perinatal Transmission of HIV in Sub‐Saharan Africa: A Comprehensive Analysis
  di: George Baah, et al.
  Pubblicazione: (2025)
• THE FACES OF VULNERABILITY - WOMEN, MOTHER, HIV POSITIVE: REFLECTIONS ON WOMEN HEALTH NURSING
  di: Isabel Catarina Correia Braga
  Pubblicazione: (2010)
• Biosocial Activism, Identities and Citizenship: Making up ‘people living with HIV and AIDS’ in Brazil
  di: Carlos Guilherme do Valle
  Pubblicazione: (2015)